Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.67 |
| ▸ | PPARD | Q03181 | 5/20 | 0.62 |
| ▸ | PPARA | Q07869 | 4/20 | 0.62 |
| ▸ | PPARG | P37231 | 3/20 | 0.62 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.60 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.59 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.58 |
| ▸ | RXRA | P19793 | 1/20 | 0.57 |
| ▸ | RXRB | P28702 | 1/20 | 0.57 |
| ▸ | RXRG | P48443 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23605980 | 0.88 | PPARA (0.75) | MAOBPPARDPPARAPPARGFFAR1 | |
| SCHEMBL4186 | 0.86 | MAOB (0.74) | MAOBPPARDPPARAPPARGPTGDR2 | |
| SCHEMBL8329343 | 0.85 | LTA4H (0.60) | PPARDPPARAPPARGFFAR1RXRA | |
| SCHEMBL21991284 | 0.85 | MAOB (0.63) | MAOBPPARDPPARAPPARGFFAR1 | |
| SCHEMBL267205 | 0.85 | RXRA (0.68) | FFAR1RXRARXRBRXRG | |
| SCHEMBL19951231 | 0.84 | MAOB (0.76) | MAOBPPARAMRGPRX4RXRARXRB | |
| SCHEMBL21991486 | 0.84 | MAOB (0.67) | MAOBPPARDPPARAPPARGFFAR1 | |
| SCHEMBL6525591 | 0.84 | MAOB (0.76) | MAOBPPARAMRGPRX4RXRARXRB | |
| SCHEMBL4759196 | 0.84 | FFAR1 (0.77) | MAOBPPARDPPARAPPARGPTGDR2 | |
| SCHEMBL1010424 | 0.84 | MAOB (0.64) | MAOBPPARDPPARAPPARGFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100130737-A1 | Regulating Agent of GPR34 Receptor Function | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-1849465-A1 | AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR | Takeda Pharmaceutical Company Limited (JP) | 2007-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130737-A1 | Regulating Agent of GPR34 Receptor Function | GPR34, GPR4, GPR6 | MAOB 3606/4885PPARD 384/4885PPARA 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.